PRP Injection for Back & Neck Pain

Targeted PRP injections for chronic back and neck pain caused by ligament laxity, facet joint degeneration and disc-related soft-tissue injury. A minimally invasive regenerative alternative to steroid injections or surgery for persistent spinal pain.

Chronic back and neck pain driven by soft-tissue degeneration, ligament laxity or facet joint irritation responds poorly to long-term anti-inflammatory medication and may not warrant surgical intervention. PRP Prolotherapy for the spine at Singapore Paincare Center offers a targeted regenerative option that addresses the structural source of pain rather than masking symptoms. The spinal PRP procedure at Singapore Paincare Center is performed by specialist pain physicians with extensive experience in interventional spinal techniques. The patient's blood is drawn and centrifuged to produce a platelet-rich concentrate, which is then injected under imaging guidance — typically fluoroscopy or ultrasound — into the precise structures implicated in the patient's pain, such as the facet joint capsules, interspinous ligaments, sacroiliac joint or paraspinal soft tissue. The growth factors released from the injected platelets stimulate local fibroblastic activity, promoting the synthesis of new collagen and the repair of degenerated ligamentous and capsular tissue. As ligament integrity improves over a course of sessions, joint stability increases and the pain signals arising from mechanically sensitive structures diminish. This mechanism differentiates PRP Prolotherapy from steroid injections, which suppress inflammation temporarily but do not promote tissue repair. Indications at Singapore Paincare Center include chronic lumbar or cervical instability, facet joint syndrome, sacroiliac joint dysfunction, degenerative disc disease with surrounding soft-tissue involvement, and persistent post-whiplash neck pain. The clinic typically recommends a series of two to four sessions, with four to six weeks between each injection, allowing time for the tissue healing response to progress before the next cycle of platelet growth factors is administered. Patients should expect mild soreness and stiffness in the treated area for two to four days after each session, which represents the initial inflammatory phase of healing. Most patients begin to notice meaningful improvement in pain and function from six to twelve weeks after commencing the course. The procedure is well tolerated, with a very low complication rate, and can be repeated if long-term maintenance is required.